[1] Diehl AM,Day C. Cause,pathogenesis,and treatment of nonalcoholic steatohepatitis. N Engl J Med,2017,377:2063-2073.
[2] Fan JG,Kim SU,Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol,2017,67:862-873.
[3] 郭锐,覃进. 随机对照试验研究熊去氧胆酸治疗原发性胆汁性肝硬化患者的 疗效及安全性. 实用肝脏病杂志,2017,20:109-110.
[4] Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol,2006,3:318-328.
[5] 张晓峰,王立福,白云峰,等. 泽泻联合熊去氧胆酸胶囊治疗非酒精性单纯性脂肪肝疗效观察. 中华中医药学刊,2012,30:274.
[6] Zhu JZ,Zhou QY,Wang YM,et al. Prevalence of fatty liver disease and the economy in China: a systematic review. World J Gastroenterol,2015,21:5695-5706.
[7] 孙晓风,周莹丽,陈君,等. 熊去氧胆酸治疗非酒精性脂肪肝的临床疗效. 肝脏,2014,19:198-199.
[8] 蔡婷婷,王薇,谢雪玲. 熊去氧胆酸联合腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症临床分析. 实用肝脏病杂志,2016,19:610-611.
[9] 宋春霞,张宝,阎志欣,等. 异甘草酸镁联合熊去氧胆酸治疗淤胆型肝炎疗效观察. 实用肝脏病杂志,2015,18:184-185. |
